List of Excipients in Branded Drug ELETRIPTAN

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Greenstone LLC	ELETRIPTAN	eletriptan hydrobromide	59762-2321	ALUMINUM OXIDE
Greenstone LLC	ELETRIPTAN	eletriptan hydrobromide	59762-2321	CELLULOSE, MICROCRYSTALLINE
Greenstone LLC	ELETRIPTAN	eletriptan hydrobromide	59762-2321	CROSCARMELLOSE SODIUM
Greenstone LLC	ELETRIPTAN	eletriptan hydrobromide	59762-2321	FD&C YELLOW NO. 6
Greenstone LLC	ELETRIPTAN	eletriptan hydrobromide	59762-2321	HYPROMELLOSE
Greenstone LLC	ELETRIPTAN	eletriptan hydrobromide	59762-2321	LACTOSE

Generic Drugs Containing ELETRIPTAN

Company	Ingredient	NDC	Excipient
Direct_Rx	eletriptan hbr	72189-439	CELLULOSE, MICROCRYSTALLINE
Direct_Rx	eletriptan hbr	72189-439	CROSCARMELLOSE SODIUM
Direct_Rx	eletriptan hbr	72189-439	FD&C YELLOW NO. 6
Direct_Rx	eletriptan hbr	72189-439	HYPROMELLOSES
Direct_Rx	eletriptan hbr	72189-439	LACTOSE MONOHYDRATE
Direct_Rx	eletriptan hbr	72189-439	MAGNESIUM STEARATE

What are the Most Frequently-Used Excipients in ELETRIPTAN?

# Of NDCs	Excipient

Excipient Strategy and Commercial Opportunities for ELETRIPTAN

Last updated: February 26, 2026

What is the Excipient Profile for ELETRIPTAN?

Eletriptan, a selective serotonin receptor agonist used to treat migraines, is formulated with specific excipients that influence its stability, bioavailability, and patient tolerability. Typically, the excipient composition supports its delivery as a tablet and may include:

• Binders: Microcrystalline cellulose
• Disintegrants: Crospovidone or sodium starch glycolate
• Fillers: Lactose monohydrate
• Lubricants: Magnesium stearate
• Coating agents: Hydroxypropyl methylcellulose (HPMC)

The precise formulation depends on the manufacturer but generally adheres to standard inputs for solid oral dosage forms.

How Does Excipient Selection Affect Eletriptan’s Pharmacokinetics and Stability?

Excipients influence drug dissolution and absorption:

• Disintegrants facilitate rapid tablet breakup in the gastrointestinal tract, promoting quick onset of action.
• Binders and fillers impact tablet integrity and uniformity, affecting bioavailability consistency.
• Lubricants prevent sticking during manufacturing but can hinder dissolution if overused.
• Coating agents protect against environmental degradation and mask taste, affecting patient compliance.

Stability studies show that with appropriate excipients, eletriptan maintains shelf life of two years under ICH conditions.

What Are Key Commercial Opportunities Through Excipient Innovation?

Innovations in excipient engineering open multiple pathways for commercial growth:

• Enhanced Bioavailability: Developing formulations with novel disintegrants could speed migraine relief, appealing to patients seeking rapid onset.
• Patient-Centric Formulations: Creating non-lactose based or allergen-free tablets broadens market access, especially in populations with lactose intolerance.
• Extended Shelf-Life: Incorporating moisture-resistant excipients can reduce degradation, minimizing supply chain losses.
• Alternative Delivery Forms: Exploring film-coated or dispersible formulations unlocks new patient segments, including pediatric or elderly populations.
• Regulatory Differentiation: Patent protection on proprietary excipient combinations or processes offers a competitive edge.

What Are Regulatory and Patent Considerations in Excipient Use?

Regulatory agencies scrutinize excipient safety and usage:

• FDA and EMA guidelines mandate safety data for excipients, especially novel or high-risk ingredients.
• Patents on specific excipient combinations can extend exclusivity, particularly if they improve drug performance or stability.
• Labeling requirements necessitate transparency on excipient composition, influencing marketability.

Manufacturers with proprietary excipient strategies can command premium pricing and negotiate better licensing terms.

How Do Excipient Choices Impact Manufacturing and Supply Chain?

The selection of excipients affects:

• Manufacturing efficiency: Flow properties and compressibility influence production speed.
• Supply chain reliability: Sourcing stable, high-quality excipients reduces risk of shortages.
• Cost management: Bulk procurement and innovative excipients can lower per-unit costs, improving margins.

Stable excipient supply chains are vital during global disruptions.

What Is the Outlook for Market Expansion and Differentiation?

Electriptan’s market primarily targets migraine sufferers, a segment worth approximately $4 billion globally. A strategic excipient approach can:

• Differentiate products through faster or more tolerable formulations.
• Enable regional expansion with formulations tailored for local preferences or regulatory environments.
• Support combination therapies by integrating excipients compatible with other active ingredients.
• Facilitate repurposing efforts for different indications, such as cluster headaches.

Conclusion

Effective excipient strategies for eletriptan emphasize optimizing pharmacokinetic properties, compliance, and manufacturing efficiency. Innovation in excipient selection and formulation can unlock new market segments and extend product life cycles. Regulatory compliance and patent protections present competitive advantages. The supply chain stability of excipients remains critical for sustained commercialization.

Key Takeaways

• Excipients influence eletriptan’s bioavailability, stability, and patient tolerability.
• Innovation in excipient formulation can improve onset speed and tolerability.
• Patent rights on novel excipient combinations provide market exclusivity.
• Market expansion depends on patient-specific formulations and supply chain robustness.
• Regulatory guidelines shape excipient selection and marketing strategies.

FAQs

1. What excipients are common in eletriptan formulations?
   Microcrystalline cellulose, crospovidone, lactose monohydrate, magnesium stearate, and HPMC are typical.

2. Can excipient modifications improve eletriptan’s onset of action?
   Yes, using fast-disintegrating or superdisintegrant excipients can accelerate dissolution and absorption.

3. Are there patent opportunities related to excipient use in eletriptan?
   Targeting unique excipient combinations or delivery technologies can create patentable formulations.

4. What regulatory hurdles exist for novel excipients in eletriptan?
   Agencies require safety data, especially for new or uncommon excipients, which can prolong approval timelines.

5. How does supply chain stability impact eletriptan manufacturing?
   Reliable sourcing of excipients ensures consistency in production, minimizes delays, and maintains market supply.

---

References

[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Excipients.
[2] European Medicines Agency. (2021). Guideline on Excipients in the Dossier for Codeine-containing medicinal products.
[3] Grand View Research. (2023). Migraine Drugs Market Size, Share & Trends.
[4] ICH Harmonised Tripartite Guideline. (2018). Stability Testing of New Drug Substances and Products.